Skip to main
NPB
NPB logo

NPB Earnings Dates & Reports

NPB Most Recent Earnings

Report DateJul 23, 2025
Period EndingQ2 2025
Est. EPS$0.52
Actual EPS$0.51
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NPB Earnings per Share (EPS) History

Signup for full access
Browse free

NPB Latest Earnings

The value each NPB share was expected to gain vs. the value each share gained.

NPB reported its most recent earnings on Jul 23, 2025 for Q2 2025, posting earnings per share (EPS) of $0.51. This exceeded analysts' expectations of $0.52 by 1.92%, marking a Miss.

For comparison, Northpointe Bancshares Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 11/18/2025, with analysts projecting an EPS of $0.52.

NPB Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 18, 2025
$0.52Next earnings call Nov. 18, 2025
Q2 2025Jul 23, 2025
$0.52$0.51-1.92%
DeckReportListen

NPB Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Northpointe Bancshares Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 22, 2025

NPB Earnings FAQs

NPB last reported earnings on Jul 23, 2025 for Q2 2025, posting an EPS of $0.51, which Miss the estimate of $0.52 by 1.92%.

For Q2 2025, NPB reported an EPS of $0.51, missing analysts' estimate of $0.52 by 1.92%.

For Q2 2025, NPB Miss expectations with an actual EPS of $0.51 vs. an estimated EPS of $0.52.

Following the last earnings report on Jul 23, 2025, NPB's stock price moved — from — to —.

The next NPB earnings call is scheduled for Nov. 18, 2025, where executives will discuss financial results and outlook.

Northpointe Bancshares Inc (NPB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.